Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026
Same author

A Major Step toward a Cure for Hepatitis B Infection.

The New England journal of medicine·2026
Same author

Hepatitis B: A Review.

JAMA·2026
Same author

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Hepatology communications·2026
Same author

A Self-Reported Electronic Body Map Identifies Distinct Clinical Pain Phenotypes in Chronic Pancreatitis.

Clinical and translational gastroenterology·2026
Same author

Animal Naming Test Predicts Future Overt Hepatic Encephalopathy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026
Same journal

H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026
Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026
See all related articles

Related Experiment Video

Updated: Jan 29, 2026

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase
07:27

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Published on: April 29, 2010

14.0K

Reply.

Anna S Lok1, William G Powderly2

  • 1Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.

Hepatology (Baltimore, Md.)
|February 15, 2019
PubMed
Summary
This summary is machine-generated.

Sustained virologic response (SVR) and direct-acting antiviral agents (DAAs) effectively treat chronic hepatitis C, improving patient outcomes. Continued research and ethical considerations support widespread treatment for all patients.

More Related Videos

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports
05:18

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

2.7K
Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry
16:11

Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry

Published on: June 8, 2022

2.8K

Related Experiment Videos

Last Updated: Jan 29, 2026

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase
07:27

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Published on: April 29, 2010

14.0K
Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports
05:18

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

2.7K
Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry
16:11

Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry

Published on: June 8, 2022

2.8K

Area of Science:

  • Hepatology
  • Virology
  • Clinical Medicine

Background:

  • The efficacy of direct-acting antiviral agents (DAAs) in treating chronic hepatitis C and achieving sustained virologic response (SVR) is supported by extensive clinical and observational data.
  • Despite accumulating evidence, the Cochrane Group has not yet recognized SVR as a validated surrogate outcome for hepatitis C treatment.

Discussion:

  • The authors express disappointment with the Cochrane Group's continued skepticism regarding SVR and DAA efficacy.
  • Numerous studies published since 2017 reinforce the clinical and patient-reported benefits of SVR and DAAs.
  • A notable outcome is the observed reduction in patients requiring liver transplantation due to hepatitis C.

Key Insights:

  • SVR achieved through DAAs significantly improves clinical and patient-reported outcomes in chronic hepatitis C.
  • Evidence from global clinical trials and observational studies robustly supports the benefits of DAA therapies.
  • There is a documented decrease in the number of patients listed for liver transplantation for hepatitis C.

Outlook:

  • The ethical imperative to treat all patients with chronic hepatitis C is underscored by the proven benefits of current therapies.
  • Further research may solidify SVR as a universally accepted surrogate endpoint in hepatitis C clinical trials.
  • Continued advocacy for widespread DAA treatment is crucial for improving global hepatitis C management.